http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-2004199-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5305109c4efec4cbcdd8bc05bdb00399
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-58
filingDate 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2300d96d0618a308cccd8fd65b3ba85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe46b72a3a0329419e585f766082e1e0
publicationDate 2005-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CZ-2004199-A3
titleOfInvention Crystalline form of risedronate monosodium
abstract Crystalline monosodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid, having the X-ray pattern with characteristic interplanar distances 4.35; 8.44; 13.42 and 15.73 รบ.
priorityDate 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452729134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11970596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4194514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408351063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454733511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414853759

Total number of triples: 27.